IECB

15/04/2019

Good morning!

Today we bring you the last plenary speaker of our 🥳: Prof. Carlos Lodeiro!!

Prof. Carlos Lodeiro combines his position as Assistant Professor in the Chemistry Department of the Faculty of Science and Technology at University NOVA of Lisbon (Portugal) with his role as co-head of the BIOSCOPE Group and the Nan@rts chemical enterprise. He is co-authored of more than 250 peer-reviewed scientific communications and a h index of 33. Among the wide range of research lines of his team, we can highlight the development of emissive smart materials, the study of the photophysics of supramolecular systems and the application of nanoparticles in biomedicine, MS spectrometry and proteomics. In particular, his group has expertise of the use of bio-analytical techniques for Protein Identification and Proteomics as well as in organic and inorganic synthesis of functionalized nanomaterials, dyes and metal composites.

Are you interested in the field? Do you want to know more? Come to the and do it!

➡️ Follow us in LinkedIn too (https://www.linkedin.com/company/yss2019/)!

10/04/2019

Good morning young researchers! We have good news for you, we extend one week the deadline for your submissions! See you soon!

15/03/2019

University of Groningen Chemistry professor Sijbren Otto works on chemical evolution. Molecules combine, grow and change in his test tubes. Can we use this t...

22/11/2018

Today at 17h00 it is Après-Ski at the IECB. Winter clothes, or at least a winter hat, is encouraged. There will be a small prize for our favourite ski costume, and also for our favourite snowflake (a surprise activity!)

21/09/2018

Today is World Alzheimer Day.

At IECB the team of Natàlia Carulla is helping to find new ways to detect the disease as early as possible. The innovative work by her team is highlighted today by the French Foundation for Medical Research (FRM).

https://www.frm.org/recherches-maladies-neurologiques/maladie-d-alzheimer/pistes-de-recherche-tres-prometteuses #2

"There is currently no reliable method for diagnosing Alzheimer's disease before its first symptoms appear. The FRM supports original and promising research avenues to identify early markers of this disease. Early diagnosis will allow the disease to slow its progression and treat it early when effective treatments are available.
We have recently demonstrated the presence of amyloid peptides in the form of covalent dimers in the brains of patients with the disease. These dimers being very stable, this would make them relevant biomarkers for detecting and monitoring the progression of the pathology. We now want to know if these dimers are present in patients' cerebrospinal fluid, and then conduct a clinical trial to confirm that their presence is indeed associated with the disease."

Identification de mécanismes moléculaires, de facteur de risque, développement de traitements… aucune piste ne doit être négligée pour lutter contre Alzheimer.

11/09/2018

Pay attention : these codes are PERSONAL & UNIQUE : 1 account = 1 participant=1 email address.If you need to register several participants, please create an account for each of them.

06/04/2017

06/10/2015

Announcing our page for the Bordeaux RNA Club!

We will be posting soon the details of the exciting 8th edition of the Bordeaux RNA Club Symposium to be held on 23-24 June 2016.

Also follow the Bordeaux RNA Club on Twitter